Apple wants its devices to be better at analyzing users’ body composition as evidenced by a newly granted patent for ...
INBS secures a key U.S. patent, strengthening its IP protection and paving the way for 2025 market entry with innovative biometric technology.
INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK ...
INBS has secured a US patent for the Intelligent Fingerprinting Drug Screening Cartridge, reinforcing drug screening ...
Company's 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company's competitive position as it prepares for planned ...
Intelligent Bio Solutions (INBS) announced that the Company has been granted a patent in the United States relating to its Intelligent ...
Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned ...
Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening technology, expanding its ...
This latest patent is part of Nirrin's expanding portfolio, reflecting the company's dedication to advancing real-time bioprocess analytics. By continuously developing groundbreaking technologies, ...
Intelligent Bio Solutions (INBS) expects to receive its sixth patent in the United States, which will strengthen the protection of the lateral ...
HID EVP Björn Lidefelt says that while 2024 brought macroeconomic headwinds with market uncertainty, long-term underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results